Braskem (BAK) Current Deferred Revenue (2009 - 2021)

Braskem (BAK) has reported Current Deferred Revenue for 13 consecutive years, with $84.6 million the latest figure, recorded in Q3 2021.

• Quarterly Current Deferred Revenue changed N/A year-over-year to $84.6 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $84.6 million (changed N/A YoY) and the FY2020 annual result came in at $70.8 million, changed N/A from the prior year.
• Current Deferred Revenue improved to $84.6 million in Q3 2021 per BAK's latest filing, from $70.8 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for BAK reached as high as $108.9 million in Q4 2017 and fell as low as $40.3 million in Q4 2018.
• A 5-year average of $77.0 million and a median of $70.8 million in 2020 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2017 — Current Deferred Revenue soared 228.38% — and 2018, when it sank 63.03%.
• Year by year, Current Deferred Revenue stood at $108.9 million in 2017, then plunged by 63.03% to $40.3 million in 2018, then soared by 85.16% to $74.5 million in 2019, then slipped by 4.96% to $70.8 million in 2020, then gained by 19.44% to $84.6 million in 2021.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $84.6 million, $70.8 million, and $74.5 million for Q3 2021, Q4 2020, and Q1 2019 respectively.